Regrelor
Regrelor (also known as INS50589) is an experimental antiplatelet drug that was under investigation by Merck Sharp and Dohme in human clinical trials. Although it was initially found to be well tolerated in healthy subjects, safety concerns led to cessation of clinical trials.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Regrelor
Regrelor (also known as INS50589) is an experimental antiplatelet drug that was under investigation by Merck Sharp and Dohme in human clinical trials. Although it was initially found to be well tolerated in healthy subjects, safety concerns led to cessation of clinical trials.
has abstract
Regrelor (also known as INS505 ...... cessation of clinical trials.
@en
CAS number
787548-03-2
ChEMBL
chemical formula
C22H25N6O8P
class
FDA UNII code
Q6C8TY6SW1
KEGG
PubChem
Wikipage page ID
54,738,072
page length (characters) of wiki page
Wikipage revision ID
997,527,572
Link from a Wikipage to another Wikipage
CAS number
ChEMBL
chemical formula
C22H25N6O8P
@en
ChemSpiderID
class
image
@en
IUPAC name
[-6-[6-purin-9-yl]-2-[-2-pheny ...... yl]methyl dihydrogen phosphate
@en
KEGG
D08983
@en
molecular weight
PubChem
11,273,179
SMILES
CCNCNC1=NC=NC2=C1N=CN2C3C4COCC=CC5=CC=CC=C5
@en
StdInChIKey
NXHAXEBZOXCDKD-XIXRRVGJSA-N
@en
UNII
Q6C8TY6SW1
@en
wikiPageUsesTemplate
subject
comment
Regrelor (also known as INS505 ...... cessation of clinical trials.
@en
label
Regrelor
@en